Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Conditions
HIV-1-infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Diego AntiViral Research Center CRS, San Diego, California, United States
Ponce de Leon Center CRS, Atlanta, Georgia, United States
Northwestern University CRS, Chicago, Illinois, United States
Massachusetts General Hospital CRS (MGH CRS), Boston, Massachusetts, United States
Washington University Therapeutics CRS, St Louis, Missouri, United States
Columbia Physicians & Surgeons CRS, New York, New York, United States
Chapel Hill CRS, Chapel Hill, North Carolina, United States
Ohio State University CRS, Columbus, Ohio, United States
Penn Therapeutics CRS, Philadelphia, Pennsylvania, United States
Houston AIDS Research Team CRS, Houston, Texas, United States
Instituto de Pesquisas em AIDS do Rio Grande do Sul - IPARGS CRS, Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil
Study leads
Sharon Riddler, MD, MPH
Study Chair
University of Pittsburgh